Investigation Overview
October 28, 2016 (Shareholders Foundation) - An investigation on behalf of investors of Juniper Pharmaceuticals Inc (NASDAQ:JNP) shares over potential securities laws violations by Juniper Pharmaceuticals and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchaser...
You must register (for free) or login to view the entire investigation.